Elevance Health, Inc. (ELV)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 12:35PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 117.14B |
| Enterprise Value | 138.33B |
| Trailing P/E | 17.69 |
| Forward P/E | 12.09 |
| PEG Ratio (5 yr expected) | 0.75 |
| Price/Sales (ttm) | 0.69 |
| Price/Book (mrq) | 2.78 |
| Enterprise Value/Revenue | 0.81 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.83 |
| 52-Week Change 3 | 13.81% |
| S&P500 52-Week Change 3 | 34.08% |
| 52 Week High 3 | 567.26 |
| 52 Week Low 3 | 435.31 |
| 50-Day Moving Average 3 | 536.00 |
| 200-Day Moving Average 3 | 517.55 |
Share Statistics
| Avg Vol (3 month) 3 | 998.93k |
| Avg Vol (10 day) 3 | 1.18M |
| Shares Outstanding 5 | 231.89M |
| Implied Shares Outstanding 6 | 231.89M |
| Float 8 | 231.36M |
| % Held by Insiders 1 | 0.19% |
| % Held by Institutions 1 | 92.33% |
| Shares Short (Sept 13, 2024) 4 | 2.2M |
| Short Ratio (Sept 13, 2024) 4 | 3.01 |
| Short % of Float (Sept 13, 2024) 4 | 0.95% |
| Short % of Shares Outstanding (Sept 13, 2024) 4 | 0.95% |
| Shares Short (prior month Aug 15, 2024) 4 | 1.67M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 6.52 |
| Forward Annual Dividend Yield 4 | 1.29% |
| Trailing Annual Dividend Rate 3 | 6.22 |
| Trailing Annual Dividend Yield 3 | 1.23% |
| 5 Year Average Dividend Yield 4 | 1.14 |
| Payout Ratio 4 | 21.78% |
| Dividend Date 3 | Sept 25, 2024 |
| Ex-Dividend Date 4 | Sept 10, 2024 |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Jun 01, 2005 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 3.90% |
| Operating Margin (ttm) | 6.93% |
Management Effectiveness
| Return on Assets (ttm) | 5.93% |
| Return on Equity (ttm) | 16.58% |
Income Statement
| Revenue (ttm) | 171.72B |
| Revenue Per Share (ttm) | 735.10 |
| Quarterly Revenue Growth (yoy) | -0.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | 11.38B |
| Net Income Avi to Common (ttm) | 6.69B |
| Diluted EPS (ttm) | 28.54 |
| Quarterly Earnings Growth (yoy) | 24.10% |
Balance Sheet
| Total Cash (mrq) | 35.99B |
| Total Cash Per Share (mrq) | 155.21 |
| Total Debt (mrq) | 30.39B |
| Total Debt/Equity (mrq) | 71.84% |
| Current Ratio (mrq) | 1.49 |
| Book Value Per Share (mrq) | 181.93 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.07B |
| Levered Free Cash Flow (ttm) | -4.66B |
© 2024 Yahoo. All rights reserved.